Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of AclarusDx™, a Blood-Based Transcriptomic Signature for the Diagnosis of Alzheimer's Disease

25 Sept 2012

Abstract excerpt

Biomarkers have gained an increased importance in the past years in helping physicians to diagnose Alzheimer's disease (AD). This study was designed to identify a blood-based, transcriptomic signature that can differentiate AD patients from control subjects. The performance of the signature was then evaluated for robustness in an independent blinded sample population. RNA was extracted from 177 blood samples (90...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Gene expression and cancer classification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22785402
DOI: 10.3233/jad-2012-120637

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of AclarusDx™, a Blood-Based Transcriptomic Signature for the Diagnosis of Alzheimer's DiseasePMID 22785402Read ↗

Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expressionSemantic proximity Read ↗

Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s DiseaseSemantic proximity Read ↗

An RNA biomarker panel for the diagnosis of Alzheimer’s disease from whole bloodSemantic proximity Read ↗

A transcriptome-wide association study identifies novel blood-based gene biomarker candidates for Alzheimer's disease risk.Semantic proximity Read ↗

Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratificationSemantic proximity Read ↗

Exploratory Single-Cell RNA Sequencing of Peripheral Blood Identifies Candidate Signatures Associated with Alzheimer’s DiseaseSemantic proximity Read ↗

Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s DiseaseSemantic proximity Read ↗

Blood-based transcriptomic biomarkers are predictive of neurodegeneration rather than Alzheimer’s diseaseSemantic proximity Read ↗

A Gene Expression Pattern in Blood for the Early Detection of Alzheimer's DiseaseSemantic proximity Read ↗

Prediction of Alzheimer’s disease using blood gene expression dataSemantic proximity Read ↗

AITeQ: A machine learning framework for Alzheimer’s prediction using a distinctive 5-gene signatureSemantic proximity Read ↗

A Novel Blood Test for the Early Detection of Alzheimer's DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.